Turning on tumors to study cancer progression

被引：12
作者：
Berns, A
机构：
[1] Netherlands Canc Inst, Div Mol Genet, NL-1066 CX Amsterdam, Netherlands
[2] Netherlands Canc Inst, Ctr Biomed Genet, NL-1066 CX Amsterdam, Netherlands
来源：
NATURE MEDICINE | 1999年 / 5卷 / 09期
关键词：
D O I：
10.1038/12421
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Despite the numerous oncogene signaling pathways that have been deciphered, no one is really sure whether drugs designed to target them will cause tumor regression in vivo. Several recently developed animal models of tumor induction provide insight into the prospects for oncogene-specific therapeutics.
引用
收藏
页码：989 / 990
页数：2
相关论文
共 8 条
  • [1] A farnesyltransferase inhibitor induces tumor regression in transgenic mice harboring multiple oncogenic mutations by mediating alterations in both cell cycle control and apoptosis
    Barrington, RE
    Subler, MA
    Rands, E
    Omer, CA
    Miller, PJ
    Hundley, JE
    Koester, SK
    Troyer, DA
    Bearss, DJ
    Conner, MW
    Gibbs, JB
    Hamilton, K
    Koblan, KS
    Mosser, SD
    O'Neill, TJ
    Schaber, MD
    Senderak, ET
    Windle, JJ
    Oliff, A
    Kohl, NE
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (01) : 85 - 92
  • [2] Essential role for oncogenic Ras in tumour maintenance
    Chin, L
    Tam, A
    Pomerantz, J
    Wong, M
    Holash, J
    Bardeesy, N
    Shen, Q
    O'Hagan, R
    Pantginis, J
    Zhou, H
    Horner, JW
    Cordon-Cardo, C
    Yancopoulos, GD
    DePinho, RA
    [J]. NATURE, 1999, 400 (6743) : 468 - 472
  • [3] Time-sensitive reversal of hyperplasia in transgenic mice expressing SV40 T antigen
    Ewald, D
    Li, MG
    Efrat, S
    Auer, G
    Wall, RJ
    Furth, PA
    Hennighausen, L
    [J]. SCIENCE, 1996, 273 (5280) : 1384 - 1386
  • [4] TRANSCRIPTIONAL ACTIVATION BY TETRACYCLINES IN MAMMALIAN-CELLS
    GOSSEN, M
    FREUNDLIEB, S
    BENDER, G
    MULLER, G
    HILLEN, W
    BUJARD, H
    [J]. SCIENCE, 1995, 268 (5218) : 1766 - 1769
  • [5] Non-Ras targets of farnesyltransferase inhibitors: focus on Rho
    Lebowitz, PF
    Prendergast, GC
    [J]. ONCOGENE, 1998, 17 (11) : 1439 - 1445
  • [6] Reversible activation of c-Myc in skin: Induction of a complex neoplastic phenotype by a single oncogenic lesion
    Pelengaris, S
    Littlewood, T
    Khan, M
    Elia, G
    Evan, G
    [J]. MOLECULAR CELL, 1999, 3 (05) : 565 - 577
  • [7] RAK J, 1995, CANCER RES, V55, P4575
  • [8] Role of the INK4a locus in tumor suppression and cell mortality
    Serrano, M
    Lee, HW
    Chin, L
    CordonCardo, C
    Beach, D
    DePinho, RA
    [J]. CELL, 1996, 85 (01) : 27 - 37
1